Alumni Association to Honor Four with Awards
April 12, 2021 by Alumni and Family Engagement
The Hope College Alumni Association is honoring four alumni with Distinguished Alumni Awards this year.
The association plans to celebrate both the 2020 and 2021 honorees virtually at a date to be determined. The awards are normally presented at the annual Alumni Banquet during Alumni Weekend each April, but this year’s and last year’s in-person events were canceled because of the ongoing global COVID-19 pandemic.
The spring 2020 honorees are the late Dr. Elton Bruins, a 1950 graduate who played a leading role in chronicling the Holland area’s and college’s history across more
Share this article
NEW YORK, March 17, 2021 /PRNewswire/ Hoth Therapeutics, Inc. (NASDAQ: HOTH), a
biopharmaceutical company, today announced entering into a Research Agreement with the University of Cincinnati Research Institute ( UCRI ) to perform critical antimicrobial characterization studies with HT-006 as part of the streamlined drug development plan. HT-006 is a novel antibiotic under development as a potential treatment for multi-drug resistant bacterial lung infections, such as hospital-acquired pneumonia (HAP), cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD) and ventilator-associated pneumonia (VAP). Hoth previously licensed the HT-006 technology for commercial evaluation from the Walter Reed Army Institute of Research. We are pleased to commence a new research program with Dr. Hassett and the University of Cincinnati Research Institute, said Robb Knie, CEO of Hoth Therapeutics. There is a growing need for new antibiotic therapies targete
Hoth Therapeutics Partners with University of Cincinnati to Perform Critical Studies for Streamlined Development of Novel Antibiotic HT-006 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Robotics platform could revolutionize how labs track the spread of COVID-19, other pathogens
A robotics platform designed by Toronto researchers to screen thousands of COVID-19 samples at once has the potential to revolutionize how labs track the spread of viruses and other pathogens, according to new findings.
The study, out Wednesday in
Nature Communications, found that the next-generation, ultra-high-throughput sequencing platform, called C19-SPAR-Seq, designed by researchers from the Lunenfeld-Tanenbaum Research Institute (LTRI) at Sinai Health, has a sensitivity rate greater than 95 per cent in positive cases during peak onset.
Identifying positive samples quickly and accurately is critical in beating this pandemic.With new and potentially dangerous variants now circulating, this is a platform that is scalable, automated and capable of analyzing thousands of COVID-19 patient samples in a single instrument run.
E-Mail
IMAGE: Jeff Wrana, left, is seen in this undated file photo at the Lunenfeld-Tanenbaum Research Institute in Toronto, Canada. view more
Credit: Sinai Health
A robotics platform designed by Toronto researchers to screen thousands of COVID-19 samples at once has the potential to revolutionize how labs track the spread of viruses and other pathogens, according to new findings.
The study, out Wednesday in
Nature Communications, found that the next-generation, ultra-high-throughput sequencing platform, called C19-SPAR-Seq, designed by researchers from the Lunenfeld-Tanenbaum Research Institute (LTRI) at Sinai Health, has a sensitivity rate greater than 95 per cent in positive cases during peak onset.